Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Short Interest Update

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) was the recipient of a large decrease in short interest during the month of April. As of April 30th, there was short interest totaling 79,768 shares, a decrease of 34.4% from the April 15th total of 121,549 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 777,518 shares, the days-to-cover ratio is currently 0.1 days.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on CLPBY shares. The Goldman Sachs Group lowered Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. Sanford C. Bernstein upgraded shares of Coloplast A/S to a “hold” rating in a report on Wednesday, January 28th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Reduce”.

Coloplast A/S Stock Performance

OTCMKTS:CLPBY opened at $6.13 on Monday. The company has a market capitalization of $13.81 billion, a P/E ratio of 43.79, a PEG ratio of 1.94 and a beta of 0.15. The company has a current ratio of 1.30, a quick ratio of 0.81 and a debt-to-equity ratio of 1.50. Coloplast A/S has a 12 month low of $6.10 and a 12 month high of $10.03. The firm has a fifty day simple moving average of $6.66 and a 200-day simple moving average of $7.91.

Coloplast A/S (OTCMKTS:CLPBY) last released its earnings results on Tuesday, May 12th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.01. The firm had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.11 billion. Coloplast A/S had a return on equity of 31.96% and a net margin of 7.46%. On average, equities research analysts anticipate that Coloplast A/S will post 0.4 earnings per share for the current year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.